EFTA00727561.pdf

10/26/2010 9:18:41 AM FROM: LABCORP LCLS BLK TO: 12125351172 LABCORP Page 3 of 4 LabgPip PattraiNuite EPSTEIN, JESTREY speommmmew 294-142-3828-0 Maria Swab,. 31143092 PatNita ID Coatrol 1•11Tilbet AE/01143392 DM< tad Time Collected 10/21/10 09:00 Date Repotted 10/26/10 Sea M AsianAM/ 59/09/01 Date of Sal 01/20/51 LabCorp Raritan 69 First Avenue Raritan NJ 08869-1800 Phone: 800-631-5250 TESTS RESULT Negative Negative Negative Negative Negative 0.2 Negative FLAG UNITS RICTERENCE INTERVAL IAS Protein Glucose Ketones Occult Blood Bilirubin Urobilinogen,Semi-On Nitrite, Urine Microscopic Examination Microscopic follows if indicated. Lipid Panel With LDL/HDL Ratio Cholesterol, Total Triglycerides RDL Cholesterol Comment According to ATP-III negative risk factor VLDL Cholesterol Cal LDL Cholesterol Cale LDL/HDL Ratio EU/dL Negative/Trace Negative Negative Negative Negative 0.0 - 1.9 Negative 226 Nigh mg/dL 100 - 199 996 Sigh mg/dL 0- 149 31 Low mg/dL >39 Guidelines, for CHD. HDL-C >59 mg/dL is considered a 79 High mg/dL 5 - 40 116 High mg/dL 0 - 99 3.7 High ratio units 0.0 - 3.6 C-Reactive Protein, Cardiac 0.79 Relative Risk for 01 01 01 01 01 01 01 01 01 01 01 01 mg/L 0.00 - 3.00 01 Future Cardiovascular Event Low <1.00 Average High 1.00 - 3.00 >3.00 Glyaohemoglobio (01b),Total Glycohemoglobin (GHb), Total 6.4 i <9.0 01 Diabetic Adult <9.0 Healthy Adult 3.9 - 7.3 (DCCT/NGSP) Current ADA guidelines recommend a treatment goal of <7.0% HgbAlc for diabetic patients, which corresponds to a <9.0% Glycohemoglobin result with this method. Prostate—Specific Ag, Serum Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01 Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory PSA value 0.2 ng/mL or greater. Values obtained with different assay methods or kits cannot be used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. EPSTEIN, JEFFREY 294-142-382B-0 Seq 12713 10/26/10 10:17 ET DUPLICATE FINAL REPORT Ths d0CIAINIX COO Win pave Le and confideanal health infoonatIon pothered by salt and federal If you have received this document mtITOT. plea se call 000-745-0233 Page 2 of 3 O20Ot1 10 Labotateey Cot potation d manta e Moldangs All Rights Reserved DOC1 Vet. 1..13 EFTA00727561 LO/26/2010 9:18:41 AM FROM: LABCORP LCLS 8LK TO: 12125351172 LABCORP Page 4 of 4 LabCcarp RmeniNnu EPSTEIN, JEFFREY SpeommNumber 294-142-3828-0 Aco Numbed 31143092 Itieml115 I CommINumbet AEA31143092 I DveasTimeColleced 10/21/10 09:00 I DueReponed 10/26/10 Su l M AgeffAVD) 59/09/01 DareaBirth 01/20/51 TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Vitamin D, 25—Hydroxy 26.9 Low ng/mL 32.0 100.0 01 Recent studies consider the lower limit of threshold for optimal health. 32.0 ng/mL to be a Hollis BW. J Nutr. 2005 Feb;135(2):317-22. Homosyst(e)ine, Plasma 12.9 umol/L 0.0 - 15.0 01 TSH 2.040 uIU/ral, 0.450 - 4.500 01 Lp-PLA2 82 Low ng/mL 131 - 199 02 Low Risk <200 Moderate Risk 200 - 235 High Risk >235 Uric Acid, Serum 7.1 mg/dL 2.4 - 8.2 01 greatine Rinams,Total,Rerum 162 U/L 24 - 204 01 LabCorp Raritan 69 First Avenue Raritan NJ 08869-1800 Phone: 800-631-5250 01 RN LabCorp Raritan 69 First Avenue, Raritan. NJ 02 BN LabCorp Burlington 1447 York Court, Burlington, For inquiries, the physician may contact 08869-1800 Dir: Michael Mahoney, MD Dir: William F Hancock, MD NC 27215-3361 Branch: 800-745-0233 Lab: 800-631-5250 EPSTEIN, JEFFREY 294-142-3828-0 Sol I VD 10/26/10 10:17 ET DUPLICATE FINAL REPORT nes documenrccatabs private an0 confidential health Information protected by sure and federal law. If you bete received this document in error, please cal) 800-745-0233 Page 3 of 3 O2004--10 Labial coy Corporation of America a Holdings AU Rights Reserved DCCI Vet: 1.43 EFTA00727562 S I • s I 10/26/2010 9:18:40 AM FROM: LABCORP LCLS BLK TO: 12125351172 LABCORP TO: KIMBERLY Woodson Merrell Page 1 of 4 LabCorp Raritan 69 First Avenue Raritan N 08869-1800 Phone.800 -762 -4344 SpsismaNimber 294-142-3820-0 PussiM CattedNmbor 60126177866 AamorNmiber 31143092 AossaMmuNtrather 212-535-1012 Route 10 NpoLamNam EPSTEIN mwmankiens Woodson Merrell 44 E 67th St New York NY 10065 Puna Pest Nast JETTAZY Peace Mittlae Name Domani Ft•ealheta 212-772-9461 Told Volume Age (YAM 59/09/01 Date of Binh 01/20/51 Sex N Faint Yes hen Address 6110 RED HOOK QUARTERS SAINT THOMAS VI 00802 Addax./ information RC: ,HS: ,TP: ,PP: ,CT: UPIN: A62553 DessedThaCollacid 10/21/10 09:00 DueBotem 10/22/10 Due aed The Rmoned 10/26/10 09:14ET Obrialw/han MERRELL , W RN 1023/53509 Mye0wID MERRELL TestrOrdeeed Arsenic, Blood; Mercury, Blood TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB Arsenic, Blood Mercury, Blood 7 2.7 ug/L 2 - 23 Detection Limit - 1 ug/L 0.0 - 14.9 Environmental Exposure: <15.0 Occupational Exposure: 01 01 BEI - Inorganic Mercury: 15.0 Detection Limit 1.0 01 BN LabCorp Burlington Dir: William F Hancock, MD 1447 York Court, Burlington, NC 27215-3361 For inquiries, the physician may contact Branch: 800-746-0233 Lab: 800-762-4344 EPSTEIN, JEFFREY 294-142-3820-0 scorn 10/26/10 10:17 ET DUPLICATE FINAL REPORT The document MUSS IMVISt and confidenbal health Informatiat prolixled by state and federal law. U you have xeceived this document 111 error, please an 800-745-0233 Page 1 of 1 02004-10 Laboratory Capaation of AMISS • Holdings AU Rights Reserved DOCI Va: 143 EFTA00727563 1.0/26/2010 9:18:40 AM FROM: LABCORP LCLS BLK TO: 12125351172 LABCORP Page 2 of 4 Lots.Cfarp SpainsoNsselm 294-142-3828-0 IssmotS, CamgMmbet AEA31143092 AcmoaNwthot 31143092 AcoomPkaeNabot Room 70 212-536-1012 Nom Um Nine EPSTEIN Accooa Address Woodson Merrell 44 E 67th St New York NY 10065 NoraPimMuse JEFFREY ftleaMakRerot Power SN Aden Roos 212-772-9461 Toed Vsne NaNAMW 59/09/01 lameolBleo 01/20/51 Sea M Fan Yes posommem 6100 RED HOOK QUARTERS SAINT THOMAS VI 00802 mmikaumwaamw UPIN: A62553 Due sod Tem Cada& 10/21/10 09:00 Cep Sewed 10/22/10 Dee sod Time Repined 10/26/10 09: 14ET Pftsiol so Nine MERRELL . W KM 1023153509 Mosioso ID MERRELL LabCorp Raritan 69 First Avenue Raritan, N 08869-1800 Phone:800-631-5250 Taw Wend Comp. Metabolic Panel (14); Urinalysis, Routine; Lipid Panel With LDL/MDL Ratio; C-Reactive Protein, Cardiac; Glycohemoglobin (OW ,Total; Prostate-Specif .c Ag, Serum; Vitamin D, 25-Hydroxy; Homocyst(e)ine, Plasma; 1551 Lp-PLA2; Uric Acid, Serum; Gneiss.). Plasma; Creatine Ki nose. Tot ol,Sorum TESTS RESULT FLAG UNITS REFERENCE INTERVAL MB Corp. Metabolic Panel (14) Glucose, Plasma BUN Creatinine, Serum eGFR eGFR AfricanAmerican 88 18 1.11 >59 >59 mg/dL mg/dL mg/dL mL/min/1.73 mL/min/1.73 65 - 99 5 - 26 0.76 - 1.27 >59 >59 01 01 01 Note: Persistent reduction for 3 months or more in an eGFR <60 mL/min/1.73 m2 defines CKD. Patients with eGFR values >1-60 mL/min/1.73 m2 may also have CKD if evidence of persistent proteinuria is present. Additional information may be found at www.kdogi.org. BUN/Creatinine Ratio 16 8 - 27 Sodium, Serum 139 mmol/L 135 - 145 01 Potassium, Serum 4.1 mmol/L 3.5 - 5.2 01 Chloride, Serum 99 mmol/L 97 - 108 01 Carbon Dioxide, Total 25 mmol/L 20 - 32 01 Calcium, Serum 9.8 m dll: 8.7 - 10.2 01 Protein, Total, Serum Albumin, Serum 7.6 4.4 g/dL c:I i 6.0 - 8.5 3.5 - 5.5 01 01 Globulin, Total 3.2 g/dL 1.5 - 4.5 A/G Ratio 1.4 1.1 - 2.5 Bilirubin, Total 0.9 mg/dL 0.0 - 1.2 01 Alkaline Phosphatase, S 60 IU/L 25 150 01 AST (SGOT) 22 IU/L 0 40 01 ALT (SGPT) 24 IU/L 0 - 55 01 Urinalysis, Routine Urinalysis Gross Exam 01 Specific Gravity 1.017 1.005 - 1.030 01 pH 6.0 5.0 - 7.5 01 Urine-Color Yellow Yellow 01 Appearance Clear Clear 01 NBC Esterase Negative Negative 01 EPSTEIN, JEFFREY 10/26/10 10:17 ET DUPLICATE FINAL REPORT Ilas document cooralas private and confidential health Information protected by state and federal law. If reline received this document in C11Of. please call S00-745-0233 294-142-3828-0 Seq /inn Page 1 of 3 02004- 10 Laboratory Corporation of America (2, Holding AU Righu Reserved DOC1 Vet: 1.41 EFTA00727564